|
1
|
Hisamatsu T, Kanai T, Mikami Y, Yoneno K,
Matsuoka K and Hibi T: Immune aspects of the pathogenesis of
inflammatory bowel disease. Pharmacol Ther. 137:283–297. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegmund B: Management of mild-to-moderate
ulcerative colitis. Dig Dis. 33(Suppl 1): 90–94. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seo GS and Chae SC: Biological therapy for
ulcerative colitis: An update. World J Gastroenterol.
20:13234–13238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang XL and Cui HF: An analysis of 10218
ulcerative colitis cases in China. World J Gastroenterol.
8:158–161. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park SJ, Kim WH and Cheon JH: Clinical
characteristics and treatment of inflammatory bowel disease: A
comparison of Eastern and Western perspectives. World J
Gastroenterol. 20:11525–11537. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Russel MG: Changes in the incidence of
inflammatory bowel disease: What does it mean? Eur J Intern Med.
11:191–196. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu L, Han L, Wong DY, Yue PY, Ha WY, Hu
YH, Wang PX and Wong RN: Effects of Si-Jun-Zi decoction
polysaccharides on cell migration and gene expression in wounded
rat intestinal epithelial cells. Br J Nutr. 93:21–29. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu X, Cui Z, Zhou Z, Shan T, Li D and Cui
N: Si-jun-zi decoction treatment promotes the restoration of
intestinal function after obstruction by regulating intestinal
homeostasis. Evid Based Complement Alternat Med. 2014:9285792014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Yang J, Cao Q and Tang J:
Therapeutic efficacy and mechanism of water-soluble extracts of
Banxiaxiexin decoction on BALB/c mice with oxazolone-induced
colitis. Exp Ther Med. 8:1201–1204. 2014.PubMed/NCBI
|
|
10
|
Myers KJ, Murthy S, Flanigan A, Witchell
DR, Butler M, Murray S, Siwkowski A, Goodfellow D, Madsen K and
Baker B: Antisense oligonucleotide blockade of tumor necrosis
factor-alpha in two murine models of colitis. J Pharmacol Exp Ther.
304:411–424. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Katti MK: Assessment of serum IL-1, IL-2
and IFN-γ levels in untreated pulmonary tuberculosis patients: Role
in pathogenesis. Arch Med Res. 42:199–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Minaiyan M, Ghassemi-Dehkordi N, Mahzouni
P and Ahmadi NS: Anti-inflammatory effect of Helichrysum
oligocephalum DC extract on acetic acid - induced acute colitis in
rats. Adv Biomed Res. 3:872014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kaneko A, Kono T, Miura N, Tsuchiya N and
Yamamoto M: Preventive effect of TU-100 on a type-2 model of
colitis in mice: Possible involvement of enhancing adrenomedullin
in intestinal epithelial cells. Gastroenterol Res Pract.
2013:3840572013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Motavallian A, Minaiyan M, Rabbani M,
Andalib S and Mahzouni P: Involvement of 5HT3 receptors in
anti-inflammatory effects of tropisetron on experimental
TNBS-induced colitis in rat. Bioimpacts. 3:169–176. 2013.PubMed/NCBI
|
|
15
|
Okayama M, Tsubouchi R, Nishio H, Kato S
and Takeuchi K: Protective effect of intra-rectal administration of
rebamipide on dextran sulfate sodium-induced rat colitis.
Digestion. 70:240–249. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Randhawa PK, Singh K, Singh N and Jaggi
AS: A review on chemical-induced inflammatory bowel disease models
in rodents. Korean J Physiol Pharmacol. 18:279–288. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Owaga E, Hsieh RH, Mugendi B, Masuku S,
Shih CK and Chang JS: Th17 cells as potential probiotic therapeutic
targets in inflammatory bowel diseases. Int J Mol Sci.
16:20841–20858. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tavakkoli H, Haghdani S, Adilipour H,
Daghaghzadeh H, Minakari M, Adibi P, Ahmadi K and Emami MH:
Serologic celiac disease in patients with inflammatory bowel
disease. J Res Med Sci. 17:154–158. 2012.PubMed/NCBI
|
|
19
|
Greenbaum E, Engelhard D, Levy R,
Schlezinger M, Morag A and Zakay-Rones Z: Mucosal (SIgA) and serum
(IgG) immunologic responses in young adults following intranasal
administration of one or two doses of inactivated, trivalent
anti-influenza vaccine. Vaccine. 22:2566–2577. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liaw FP, Lau LC, Lim AS, Lim TH, Lee GY
and Tien SL: CpG oligonucleotide and interleukin 2 stimulation
enables higher cytogenetic abnormality detection rates than
12-o-tetradecanolyphorbol-13-acetate in Asian patients with B-cell
chronic lymphocytic leukemia (B-CLL). Int J Hematol. 100:545–553.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cho JH, Boyman O, Kim HO, Hahm B,
Rubinstein MP, Ramsey C, Kim DM, Surh CD and Sprent J: An intense
form of homeostatic proliferation of naive CD8+ cells driven by
IL-2. J Exp Med. 204:1787–1801. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu DH, Bao YM, An LJ and Yang M:
Protection of PC12 cells against superoxide-induced damage by
isoflavonoids from Astragalus mongholicus. Biomed Environ Sci.
22:50–54. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xie F, Sakwiwatkul K, Zhang C, Wang Y,
Zhai L and Hu S: Atractylodis macrocephalae Koidz. polysaccharides
enhance both serum IgG response and gut mucosal immunity. Carbohydr
Polym. 91:68–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
